Skip to main content
Clinical Trials/CTRI/2022/05/042463
CTRI/2022/05/042463
Recruiting
Phase 2

Randomized Controlled Trials to evaluate the effects of Shatavari (Asparagus racemosus) on the quality of life and muscle strength of post-menopausal females and women during menstruation alongwith effect on lactation on breastfeeding mothers and muscle strength among males.

ihar Ranjan Pradhan0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ihar Ranjan Pradhan
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ihar Ranjan Pradhan

Eligibility Criteria

Inclusion Criteria

  • Women who have attained menopause
  • Able to take the drug orally and comply with study procedures;

Exclusion Criteria

  • Consumption of other oral probiotic supplements during the trial;
  • Patients with severe underlying diseases that affects survival, including uncontrolled malignant tumor with multiple metastases that cannot be resected,
  • Blood diseases,
  • Active bleeding,
  • Severe malnutrition
  • Patients allergic to systemic enzyme supplements;
  • Patients facing imminent death in the opinion of the clinical team;
  • Patients with Hb less than 10 g/dl;
  • Patients who have participated in any other clinical study within 2 weeks prior to randomization

Outcomes

Primary Outcomes

Not specified

Similar Trials